CB Financial Statements & Analysis
Complete financial statements for CB including income statement, balance sheet, and cash flow statement. Analyze CB's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
51
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
12.0% ↑
Net Income
2.7% ↑
Gross Margin
4.3% ↑
Operating Margin
6.8% ↑
Balance Sheet
Current Ratio
24.5% ↑
Debt to Equity
-2.7% ↑
Asset Turnover
4.8% ↑
Cash Flow
Operating Cash Flow
28.1% ↑
Net Cash Flow
-114.6% ↓
Free Cash Flow
28.1% ↑
Cash Flow to Debt
22.3% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 50.13B | 56.15B | 12.0% | |
| Gross Profit | 13.84B | 16.17B | 16.9% | |
| Operating Income | 10.20B | 12.20B | 19.6% | |
| Net Income | 9.03B | 9.27B | 2.7% | |
| EPS | 21.97 | 22.94 | 4.4% | |
| EBITDA | 10.51B | 12.52B | 19.1% | |
| Gross Margin | 27.60% | 28.80% | 4.3% | |
| Operating Margin | 20.34% | 21.72% | 6.8% | |
| Net Income Margin | 18.01% | 16.51% | 8.3% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 56.15B | 50.13B | 42.98B | 40.77B | 36.05B |
| Gross Profit | 16.17B | 13.84B | 10.83B | 11.33B | 36.05B |
| Operating Income | 12.20B | 10.20B | 7.05B | 10.29B | 4.16B |
| Net Income | 9.27B | 9.03B | 5.25B | 8.53B | 3.53B |
| EPS | 22.94 | 21.97 | 12.5 | 19.38 | 7.82 |
| EBITDA | 12.52B | 10.51B | 7.34B | 10.57B | 4.97B |
| Gross Margin | 28.80% | 27.60% | 25.20% | 27.80% | 100.00% |
| Operating Margin | 21.72% | 20.34% | 16.42% | 25.23% | 11.54% |
| Net Income Margin | 16.51% | 18.01% | 12.21% | 20.91% | 9.80% |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 |